Evidence map›Paper›PMID 42859588›Full record

ArticleHealth affairs scholar2026

Building on the 2025 National Academies Pharmacy Workshop: pharmacy deserts in the United States.

Lucas A Berenbrok, Delesha Carpenter, Teresa M Salgado, Marie Chisholm-Burns, Jenny S Guadamuz, Elizabeth Hall-Lipsy, Cherokee Layson-Wolf, Whitney D Maxwell, Heidi R Olson, Megan R Undeberg and 2 more

Abstract read
In one paragraph

Article in Health affairs scholar, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lucas A BerenbrokUniversity of Pittsburgh School of Pharmacy, Department of Pharmacy and Therapeutics, Pittsburgh, PA 15261, USA.ORCID https://orcid.org/0000-0001-9479-8209
Delesha CarpenterThe University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Division of Pharmaceutical Outcomes and Policy, Chapel Hill, NC 27599, USA.ORCID https://orcid.org/0000-0003-2025-8140
Teresa M SalgadoVirginia Commonwealth University School of Pharmacy, Department of Pharmacotherapy and Outcomes Science, Richmond, VA 23298, USA.ORCID https://orcid.org/0000-0003-2708-7145
Marie Chisholm-BurnsOregon Health & Science University, Portland, OR 97239, USA.ORCID https://orcid.org/0000-0002-6090-6547
Jenny S GuadamuzUniversity of California, Berkeley, School of Public Health, Division of Health Policy and Management, Berkeley, CA 94720, USA.ORCID https://orcid.org/0000-0002-2312-4140
Elizabeth Hall-LipsyThe University of Arizona College of Pharmacy, Tucson, AZ 85721, USA.ORCID https://orcid.org/0000-0002-6500-3339
Cherokee Layson-WolfUniversity of Maryland School of Pharmacy, Department of Practice, Sciences and Health Outcomes Research, Baltimore, MD 21201, USA.ORCID https://orcid.org/0000-0002-1684-3489
Whitney D MaxwellUniversity of South Carolina College of Pharmacy, Department of Clinical Pharmacy and Outcomes Sciences, Columbia, SC 29208, USA.ORCID https://orcid.org/0000-0002-3287-6758
Heidi R OlsonUniversity of Illinois Chicago, Retzky College of Pharmacy at Rockford, Department of Pharmacy Practice, Rockford, IL 61107, USA.ORCID https://orcid.org/0009-0001-1413-4224
Megan R UndebergWashington State University College of Pharmacy and Pharmaceutical Sciences, Department of Pharmacotherapy, Spokane, WA 99202, USA.ORCID https://orcid.org/0000-0001-9415-2520
Stevie VeachThe University of Iowa College of Pharmacy, Department of Pharmacy Practice and Science, Iowa City, IA 52242, USA.ORCID https://orcid.org/0000-0002-8519-0741
Vicki L EllingrodUniversity of Michigan College of Pharmacy, Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0001-8289-4834

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Areas with no access or limited access to community pharmacies are routinely referred to as "pharmacy deserts," which are of growing concern in the United States. In addition to medication dispensing, community pharmacies offer a variety of healthcare services that keep populations and individuals healthy. Our objective is to present an overview of pharmacy deserts in the United States, discuss the impact of reduced pharmacy access for Americans, and propose solutions discussed at the 2025 Innovations in Pharmacy Training and Sustainable Practice to Advance Patient Care: A Workshop at the National Academies in Washington, D.C. Policy and legislation that ensure the financial sustainability of community pharmacies as staples of healthcare delivery in local neighborhoods should consider these multimodal solutions to ensure pharmacy access for all populations in the United States.

Indexed as

healthcare accesspharmacy accesspharmacy deserts

Identifiers

PMID42859588
PMCPMC13653339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.